1. Zaritskey A., Afanasiev B. Clinical signisicance of p53 and mdr-1 gene expression in AML patients. Blut, N3, p.237, abstr. 668, 1994.
2. Zaritskey A., Bykova T., Stuif I., Sominskaya A., Medvedeva N., Anikina N., Afanasiev B. Prognoistic significance and relationship of myc and mdr-1 gene expression in adult acute leukemia. Modern Trends in Human Leukemia, 1995, in press.
3. Andreef M., Zhao S., Drach D., Hegewish S. et al. Expression of multidrug resistance and p53 genes in hematological cell systems: implications for biology and gene therapy. Cancer Bull, 1993, v.45, pl31–138.
4. Drach D., Zhao Z., Drach Y., Mahadevia R., Gatringer C., Huber H., Andreef M. Subpopulations on normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood, 1992, v.80, p.2729.
5. Shidzinsky S., Brellwiz S., Feldman S.C., Watt R.A. Participation of c-myc-protein in DNA synthesis of human cells. Science, v.457, p.467, 1986.